{
    "Title": "Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials",
    "URL": "https://doi.org/10.1371/journal.pntd.0004821",
    "Published": "July 14, 2016",
    "Subject_Areas": [
        "Dengue fever",
        "Vaccine development",
        "Viral vaccines",
        "Viremia",
        "Phase III clinical investigation",
        "Attenuated vaccines",
        "Vaccination and immunization",
        "Antigens"
    ],
    "Authors": {
        "Sophia Gailhardou": [
            "Sanofi Pasteur, Lyon, France"
        ],
        "Anna Skipetrova": [
            "Sanofi Pasteur, Lyon, France"
        ],
        "Gustavo H. Dayan": [
            "Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America"
        ],
        "John Jezorwski": [
            "Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America"
        ],
        "Melanie Saville": [
            "Sanofi Pasteur, Lyon, France"
        ],
        "Diane Van der Vliet": [
            "Sanofi Pasteur, Marcy lâ€™Etoile, France"
        ],
        "T. Anh Wartel": [
            "Sanofi Pasteur, Singapore"
        ]
    }
}